| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |